Major histocompatibility complex class I expression impacts on patient survival and type and density of immune cells in biliary tract cancer

[1] Boon T(1994)Tumour antigens recognized by T lymphocytes Annu Rev Immunol 12 337-365

[2] Cerottini JC(2015)Nivolumab versus Docetaxel in advanced squamous-cell non-small-cell lung cancer N Engl J Med 373 123-135

[3] Van den Eynde B(2003)Analysis of HLA expression in human tumour tissues Cancer Immunol Immunother 52 1-9

[4] van der Bruggen P(2008)HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance Oncogene 27 5869-5885

[5] Van Pel A(2011)The immunoregulatory mechanisms of carcinoma for its survival and development J Exp Clin Cancer Res 30 12-360

[6] Brahmer J(2004)The three Es of cancer immunoediting Annu Rev Immunol 22 329-8311

[7] Reckamp KL(2015)Melanoma: CheckMate 067-frontline nivolumab improves PFS alone or in combination with ipilimumab Nat Rev Clin Oncol 12 435-e31

[8] Baas P(2005)Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumours Clin Cancer Res 11 8304-1964

[9] Crino L(2004)CD8+ tumour-infiltrating lymphocytes together with CD4+ tumour-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma Pancreas 28 e26-2028

[10] Eberhardt WE(2006)Type, density, and location of immune cells within human colorectal tumours predict clinical outcome Science 313 1960-256

[1] Boon T(1994)Tumour antigens recognized by T lymphocytes Annu Rev Immunol 12 337-365

[2] Cerottini JC(2015)Nivolumab versus Docetaxel in advanced squamous-cell non-small-cell lung cancer N Engl J Med 373 123-135

[3] Van den Eynde B(2003)Analysis of HLA expression in human tumour tissues Cancer Immunol Immunother 52 1-9

[4] van der Bruggen P(2008)HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance Oncogene 27 5869-5885

[5] Van Pel A(2011)The immunoregulatory mechanisms of carcinoma for its survival and development J Exp Clin Cancer Res 30 12-360

[6] Brahmer J(2004)The three Es of cancer immunoediting Annu Rev Immunol 22 329-8311

[7] Reckamp KL(2015)Melanoma: CheckMate 067-frontline nivolumab improves PFS alone or in combination with ipilimumab Nat Rev Clin Oncol 12 435-e31

[8] Baas P(2005)Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumours Clin Cancer Res 11 8304-1964

[9] Crino L(2004)CD8+ tumour-infiltrating lymphocytes together with CD4+ tumour-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma Pancreas 28 e26-2028

[10] Eberhardt WE(2006)Type, density, and location of immune cells within human colorectal tumours predict clinical outcome Science 313 1960-256